Page 121 - Human Lyme Neuroborreliosis

Treatment 105

[11] Thorstrand C, Belfrage E, Bennet R, et al. Successful treatment of
neuroborreliosis with ten day regimens. Pediatr Infect Dis J 2002;
21:1142-1145.

[12] Kohlhepp W, Oschmann P, Mertens HG. Treatment of Lyme
borreliosis. Randomized comparison of doxycycline and penicillin G. J
Neurol 1989; 236:464-469.

[13] Sköldenberg B, Stiernstedt G, Karlsson M, et al. Treatment of Lyme
borreliosis with emphasis on neurological disease. Ann NY Acad Sci
1988; 539:317-323.

[14] Krüger H, Kohlhepp W, König S. Follow-up of antibiotically treated and
untreated neuroborreliosis. Acta Neurol Scand 1990; 82:59-67.

[15] French J, Gronseth G. Invited article: Lost in a jungle of evidence.
Neurology 2008; 71:1634-1638.

[16] Gross RA, Johnston KC. Levels of evidence. Taking Neurology to the
next level. Neurology 2009; 72:8-10.

[17] Steere AC, Coburn J, Glickstein L. The emergence of Lyme disease. J
Clin Invest 2004; 113:1093-1101.

[18] Younger DS. Lyme neuroborreliosis. Chapter 33. In, DS Younger, ed.
Motor Disorders, 3rd edition. David S Younger MD PC: New York;
575-581.

[19] https://rothsteinpublishing.com/motor-disorders-younger/.
[20] Steere AC, Falk B, Drouin EE, et al. Binding of outer surface protein A

and human lymphocytic function-associated antigen 1 peptides to HLA-
DR molecules associated with antibiotic-resistant Lyme arthritis.
Arthritis Rheum 2003; 48:534-540.
[21] Steere AC. Treatment of Lyme arthritis. Arthritis Rheum 1994; 37:878-
888.
[22] Steere AC, Glicktein L. Elucidation of Lyme arthritis. Nat Rev Immunol
2004; 4:143-152.
[23] Reimers CD, Neubert U, Kristoferistch, Pflüger W, et al. Borrelia
burgdorferi infection in Europe: an HLA-related disease? Infection
1992; 20:197-200.
[24] Younger DS, Orsher S. Lyme Neuroborreliosis: Preliminary Results
from an Urban Referral Center Employing Strict CDC Criteria for Case
Selection. Neurol Res Int 2010; 2010:525206.

Complimentary Contributor Copy